(Q53356377)

13 May 2018

title

Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma. (English)

1 reference

13 May 2018

1 reference

Barbara Tringler

1

1 reference

13 May 2018

Christoph Grimm

2

1 reference

13 May 2018

Gerhard Sliutz

3

1 reference

13 May 2018

Sepp Leodolter

4

1 reference

13 May 2018

Paul Speiser

5

1 reference

13 May 2018

Alexander Reinthaller

6

1 reference

13 May 2018

Lukas A Hefler

7

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 October 2005

1 reference

13 May 2018

published in

Gynecologic Oncology

1 reference

13 May 2018

volume

99

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

80-83

1 reference

13 May 2018

Physiology of Thrombospondin

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Expression of thrombospondin-1 in cancer: a role in tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Phosphatidylinositol 3-kinase and focal adhesion kinase are early signals in the growth factor-like responses to thrombospondin-1 seen in human vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

The effect of thrombospondin on oral squamous carcinoma cell invasion of collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

The effect of thrombospondin-1 and TGF-beta 1 on pancreatic cancer cell invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Thrombospondin-1 expression in oral squamous cell carcinomas: correlations with tumor vascularity, clinicopathological features and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.038

10.1016/J.YGYNO.2005.05.038

7 January 2021

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018